Salient Features:
The MoU aims at cooperation in areas of common interest within the medical, life sciences and health research fields. Based on scientific excellence on both sides, the parties have agreed to have a specific focus upon:
i. Diabetes and Metabolic disorders;
ii. Bio-ethics with focus on Ethics and regulatory issues of Gene editing techniques;
iii. Rare diseases; and
iv. Any other areas of mutual interest can be considered after discussions between the two sides.
The MoU will further strengthen relations between ICMR and INSERM within the framework of international scientific and technological cooperation in fields of mutual interest. The scientific excellence on two sides will help to successfully work on health research in specified areas.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
